Anti-Procainamide Antibody (16704)
Anti-Procainamide Antibody (16704)
Product No.: 16704
- -
- -
Clone PC12-416.1.1 Target Procainamide Formats AvailableView All Product Type Monoclonal Isotype Mouse IgG1 Applications ELISA |
Data
- -
- -
Antibody DetailsProduct DetailsReactive Species Procainamide Host Species Mouse Immunogen Procainamide-KLH. Product Concentration Lot Specific Formulation This monoclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.2 - 7.4 with no carrier protein or preservatives added. State of Matter Liquid Product Preparation Antibodies are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Upon initial thawing, appropriately aliquot and store at -80°C. For long-term storage, keep at -80°C. Avoid repeated freeze-thaw cycles. Country of Origin USA Shipping Next Day 2-8°C Applications and Recommended Usage? Quality Tested by Leinco These antibodies have been qualified for use in ELISA to detect procainamide. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity This mouse monoclonal antibody is specific to procainamide and shows 11.3% cross-reactivity with N-acetylprocainamide . Background Procainamide is an antiarrhythmic used to treat cardiac arrhythmias. It induces rapid block of the batrachotoxin (BTX)-activated sodium channels of the heart muscle and acts as antagonist to long gating closures. Procainamide is metabolized via different pathways. The most common one is the acetylation of procainamide to the less toxic N- acetylprocainamide. Procainamide was approved by the US FDA on June 2, 1950. Research Area Drugs References & CitationsTechnical ProtocolsCertificate of Analysis |
Formats Available
